Teladoc Health (TDOC) Cash from Investing Activities (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Cash from Investing Activities data on file, last reported at -$36.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 70.37% year-over-year to -$36.5 million; the trailing twelve-month figure through Mar 2026 stood at -$179.3 million (up 15.37% YoY), and the FY2025 full-year result was -$266.0 million, down 114.43% from the prior year.
• Cash from Investing Activities declined to -$36.5 million in Q1 2026, from -$34.3 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$27.6 million in Q1 2022 to a low of -$123.3 million in Q1 2025.
• A 5-year average of -$44.2 million and a median of -$36.6 million in 2023 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities sank 1968.13% in 2022 and surged 70.37% in 2026, its largest moves.
• Tracing TDOC's Cash from Investing Activities over 5 years: stood at -$53.9 million in 2022, then jumped by 32.26% to -$36.5 million in 2023, then rose by 18.8% to -$29.6 million in 2024, then fell by 15.77% to -$34.3 million in 2025, then retreated by 6.42% to -$36.5 million in 2026.
• Business Quant data shows TDOC's Cash from Investing Activities at -$36.5 million in Q1 2026, -$34.3 million in Q4 2025, and -$48.7 million in Q3 2025.